Blockade of IL-33/ST2 ameliorates airway inflammation in a murine model of allergic asthma

Experimental Lung Research

Volumn 40, Issue 2, 2014, Pages 66-76

  Lee, Hea Yon ^a   Rhee, Chin Kook ^a   Kang, Ji Young ^a   Byun, Ji Hae ^b   Choi, Joon Young ^a   Kim, Seung Joon ^a   Kim, Young Kyoon ^a   Kwon, Soon Suk ^a   Lee, Sook Young ^a  

^a The Catholic University of Korea   (South Korea)

^b Korea University   (South Korea)

Author keywords

Allergy; Asthma; Inflammation; Interleukin 33; Soluble ST2

Indexed keywords

ANIMALS; ANTIBODIES, ANTI-IDIOTYPIC; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INTERLEUKINS; MICE; MICE, INBRED BALB C; OVALBUMIN; PNEUMONIA; RECEPTORS, INTERLEUKIN; SIGNAL TRANSDUCTION; TH2 CELLS;

EID: 84894113136     PISSN: 01902148     EISSN: 15210499     Source Type: Journal    
DOI: 10.3109/01902148.2013.870261     Document Type: Article

References (38)

1. Greenfeder S, Umland SP, Cuss FM, Chapman RW, Egan RW: Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res. 2001;2:71-79.
2. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, Foster PS, Rothenberg ME: IL-13 induces eosinophil recruitment into the lung by an IL-5- And eotaxin-dependent mechanism. J Allergy Clin Immunol. 2001;108:594-601.
3. Lukacs NW, Strieter RM, Chensue SW, Kunkel SL: Interleukin-4-dependent pulmonary eosinophil infiltration in a murine model of asthma. Am J Respir Cell Mol Biol. 1994;10:526-532.
4. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, Mc- Clanahan TK, Zurawski G, Moshrefi M, Qin J, Li X, Gorman DM, Bazan JF, Kastelein RA: IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity. 2005;23:479-490.
5. Kurowska-Stolarska M, Kewin P, Murphy G, Russo RC, Stolarski B, Garcia CC, Komai-Koma M, Pitman N, Li Y, Niedbala W, McKenzie AN, Teixeira MM, Liew FY, Xu D: IL- 33 induces antigen-specific IL-5+ T cells and promotes allergicinduced airway inflammation independent of IL-4. J Immunol. 2008;181:4780-4790.
6. Stolarski B, Kurowska-Stolarska M, Kewin P, Xu D, Liew FY: IL-33 exacerbates eosinophil-mediated airway inflammation. J Immunol. 2010;185:3472-3480.
7. Palmer G, Gabay C: Interleukin-33 biology with potential insights into human diseases. Nat Rev Rheumatol. 2011;7:321-329.
8. Coyle AJ, Lloyd C, Tian J, Nguyen T, Erikkson C, Wang L, Ottoson P, Persson P, Delaney T, Lehar S, Lin S, Poisson L, Meisel C, Kamradt T, Bjerke T, Levinson D, Gutierrez-Ramos JC: Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses. J Exp Med. 1999;190:895-902.
9. HayakawaH, HayakawaM, Kume A, Tominaga S: Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem. 2007;282:26369-26380.
10. Lee JH,Wang LC, Yu HH, Lin YT, Yang YH, Chiang BL: Type I IL-1 receptor (IL-1RI) as potential new therapeutic target for bronchial asthma. Mediators Inflamm. 2010;2010:567351. doi: 10.1155/2010/567351.
11. Pŕefontaine D, Nadigel J, Chouiali F, Audusseau S, Sernlali A, Chakir J, Martin JG, Hamid Q: Increased IL-33 expression by epithelial cells in bronchial asthma. J Allergy Clin Immunol. 2010;125:752-754.
12. Kondo Y, Yoshimoto T, Yasuda K, Futatsugi-Yumikura S, Morimoto M, Hayashi N, Hoshino T, Fujimoto J, Nakanishi K: Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system. Int Immunol. 2008;20:791-800.
13. Zhiguang X,Wei C, Steven R,Wei D,Wei Z, RongM, Zhanguo L, Lianfeng Z: Over-expression of IL-33 leads to spontaneous pulmonary inflammation in mIL-33 transgenic mice. Immunol Lett. 2010;131:159-165.
14. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, Ishii A, Nambu A, Abe T, Kiyonari H, Matsumoto K, Sudo K, Okumura K, Saito H, Nakae S: IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci USA. 2010;107:18581-18586.
15. Yagami A, Orihara K, Morita H, Futamura K, Hashimoto N, Matsumoto K, Saito H, Matsuda A: IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol. 2010;185:5743-5750.
16. Liu X, Li M, Wu Y, Zhou Y, Zeng L, Huang T: Anti-IL-33 antibody treatment inhibits airway inflammation in a murine model of allergic asthma. Biochem Biophys Res Commun. 2009;386:181-185.
17. Kim YH, Park CS, Lim DH, Ahn SH, Son BK, Kim JH, Jang TY: Beneficial effect of anti-interleukin-33 on the murine model of allergic inflammation of the lower airway. J Asthma. 2012;49:738-743.
18. Townsend MJ, Fallon PG, Matthews DJ, Jolin HE, McKenzie AN: T1/ST2-deficient mice demonstrate the importance of T1/ST2 in developing primary T helper cell type 2 responses. J Exp Med. 2000;191:1069-1076.
19. Senn KA, McCoy KD, Maloy KJ, Stark G, Fröhli E, Rülicke T, Klemenz R: T1-deficient and T1-Fc-transgenic mice develop a normal protective Th2-type immune response following infection with Nippostrongylus brasiliensis. Eur J Immunol. 2000;30:1929-1938.
20. Cherry WB, Yoon J, Bartemes KR, Iijima K, Kita H: A novel IL- 1 family cytokine, IL-33, potently activates human eosinophils. J Allergy Clin Immunol. 2008;121:1484-1490.
21. Chow JY,WongCK, Cheung PF, Lam CW: Intracellular signaling mechanisms regulating the activation of human eosinophils by the novel Th2 cytokine IL-33: Implications for allergic inflammation. Cell Mol Immunol. 2010;7:26-34.
22. Hogan SP, Koskinen A, Foster PS: Interleukin-5 and eosinophils induce airway damage and bronchial hyperreactivity during allergic airway inflammation in BALB/c mice. Immunol Cell Biol. 1997;75:284-288.
23. Saenz SA, Taylor BC, Artis D: Welcome to the neighborhood: Epithelial cell-derived cytokines license innate and adaptive immune responses at mucosal sites. Immunol Rev. 2008;226:172-190.
24. Yang Q, Li G, Zhu Y, Liu L, Chen E, Turnquist H, Zhang X, Finn OJ, Chen X, Lu B: IL-33 synergizes with TCR and IL-12 signaling to promote the effector function of CD8+ T cells. Eur J Immunol. 2011;41:3351-3360.
25. Smithgall MD, Corneau MR, Yoon BR, Kaufman D, Armitage R, Smith DE: IL-33 amplifies both Th1- And Th2- type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol. 2008;20:1019-1030.
26. Savinko T, Karisola P, Lehtimaki S, Lappetelainen AM, Haapakoski R, Wolff H, Lauerma A, Alenius H: ST2 regulates allergic airway inflammation and T-cell polarization in epicutaneously sensitized mice. J Invest Dermatol. 2013;133: 2522-2529.
27. Adler A, Cieslewicz G, Irvin CG: Unrestrained plethysmography is an unreliablemeasure of airway responsiveness in BALB/c and C57BL/6 mice. J Appl Physiol. 2004;97:286-292.
28. Bates J, Irvin C, Brusasco V, Drazen J, Fredberg J, Loring S, Eidelman D, Ludwig M, Macklem P, Martin J, Milic-Emili J, Hantos Z, Hyatt R, Lai-Fook S, Leff A, Solway J, Lutchen K, Suki B, Mitzner W, Pare P, Pride N, Sly P: The use and misuse of Penh in animal models of lung disease. Am J Respir CellMol Biol. 2004;31:373-374.
29. Giri JG, Wells J, Dower SK, McCall CE, Cuzman RN, Slack J, Bird TA, Shanebeck K, Grabstein KH, Sims JE, Alderson MR: Elevated levels of shed type II IL-1 receptor in sepsis. Potential role for type II receptor in regulation of IL-1 responses. J Immunol. 1994;153:5802-5809.
30. Sato TA, Widmer MB, Finkelman FD, Madani H, Jacobs CA, Grabstein KH, Maliszewski CR: Recombinant soluble murine Il-4 receptor can inhibit or enhance IgE responses in vivo. J Immunol. 1993;150:2717-2723.
31. Xu W, Presnell SR, Parrish-Novak J, Kindsvogel W, Jaspers S, Chen Z, Dillon SR, Gao Z,Gilbert T,Madden K, Schlutsmeyer S, Yao L, Whitmore TE, Chandrasekher Y, Grant FJ, Maurer M, Jelinek L, Storey H, Brender T, Hammond A, Topouzis S, Clegg CH, Foster DC: A soluble class II cytokine receptor, IL-22RA2, is a naturally occurring IL-22 antagonist. Proc Natl Acad Sci USA. 2001;98:9511-9516.
32. Hurst SM, Wilkinson TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N, Rose-John S, Fuller GM, Topley N, Jones SA: IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity. 2001;14:705-714.
33. Leung BP, Xu D, Culshaw S, McInnes IB, Liew FY: A novel therapy of murine collagen-induced arthritis with soluble T1/ST2. J Immunol. 2004;173:145-150.
34. Fagundes CT, Amaral FA, Souza AL, Vieira AT, Xu D, Liew FY, Souza DG, Teixeira MM: ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. J Leukoc Biol. 2007;81:492-499.
35. Yin H, Huang BJ, Yang H, Huang YF, Xiong P, Zheng F, Chen XP, Chen YF, Gong FL: Pretreatment with soluble ST2 reduces warm hepatic ischemia/reperfusion injury. Biochem Biophys Res Commun. 2006;351:940-946.
36. Yin H, Li XY, Liu T, Yuan BH, Zhang BB, Hu SL, Gu HB, Jin XB, Zhu JY: Adenovirus-mediated delivery of soluble ST2 attenuates ovalbumin-induced allergic asthma in mice. Clin Exp Immunol. 2012;170:1-9.
37. Gachter T, Werenskiold AK, Klemenz R: Transcription of the interleukin-1 receptor-related T1 gene is initiated at different promoters in mast cells and fibroblasts. J Biol Chem. 1996;271:124-129.
38. Oshikawa K, Yanagisawa K, Tominaga S, Sugiyama Y: Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy. 2002;32:1520-1526.